Gijs van den Brink,
Chief Scientific Officer
Gijs joined Granite-Bio as CSO in 2025 and is also an operating partner at Forbion. Gijs was previously at Roche, where he served as SVP and Global Head of Immunology, CVM, ID, and Ophthalmology Discovery and Early Development, member of the Pharma Research and Early Development (pRED) leadership team. In his role, Gijs drove transformative initiatives that enhanced R&D productivity, strengthened cross-functional collaborations, and supported strategic acquisitions.
Before transitioning to industry, Gijs earned his MD & PhD from the University of Amsterdam Medical Center and completed specialized training in internal medicine and gastroenterology at leading institutions in Amsterdam, Geneva, and Leiden. He served as board-certified gastroenterologist and Professor of Experimental Gastroenterology at the University of Amsterdam, where he led groundbreaking discovery and translational research in inflammatory bowel disease. Throughout his career, Gijs has co-authored over 150 peer-reviewed scientific publications.